343 Multiomic biomarker signatures identify subsets of patients who may benefit from either nivolumab or sotigalimab in combination with chemotherapy in metastatic pancreatic cancer

Deena Maurer; Jia Xin Yu; Kamil Sklodowski; Marco Tognetti; Lukas Reiter; Roland Bruderer; Jakob Vowinckel; Shannon Pfeiffer; Mark O’Hara; Eileen O’Reilly; Robert Wolff; Zev Wainberg; Andrew Ko; Osama Rahm; George Fisher; Jaclyn Lyman; Christopher Cabanski; Pier Federico Gherardini; Jill O’Donnell-Tormey; Theresa LaVallee; Robert Vonderheide; Lacey Kitch

doi:10.1136/jitc-2021-SITC2021.343

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials Completed

343 Multiomic biomarker signatures identify subsets of patients who may benefit from either nivolumab or sotigalimab in combination with chemotherapy in metastatic pancreatic cancer

Free

Authors

Deena Maurer Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Jia Xin Yu Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Kamil Sklodowski Biognosys, Schileren, Switzerland PubMed articles Google scholar articles
Marco Tognetti Biognosys, Schileren, Switzerland PubMed articles Google scholar articles
Lukas Reiter Biognosys, Schileren, Switzerland PubMed articles Google scholar articles
Roland Bruderer Biognosys, Schileren, Switzerland PubMed articles Google scholar articles
Jakob Vowinckel Biognosys, Schileren, Switzerland PubMed articles Google scholar articles
Shannon Pfeiffer Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Mark O’Hara Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA, USA PubMed articles Google scholar articles
Eileen O’Reilly Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articles Google scholar articles
Robert Wolff University of Texas MD Anderson Cancer, Houston, TX, USA PubMed articles Google scholar articles
Zev Wainberg University of California, Los Angeles, Santa Monica, CA, USA PubMed articles Google scholar articles
Andrew Ko University of California, San Francisco, San Francisco, CA, USA PubMed articles Google scholar articles
Osama Rahm Dana-Farber Cancer Institute, Boston, MA, USA PubMed articles Google scholar articles
George Fisher Stanford University School of Medicine, Stanford, CA, USA PubMed articles Google scholar articles
Jaclyn Lyman Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Christopher Cabanski Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Pier Federico Gherardini Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Jill O’Donnell-Tormey Cancer Research Institute, New York, NY, USA PubMed articles Google scholar articles
Theresa LaVallee Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles
Robert Vonderheide Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA, USA PubMed articles Google scholar articles
Lacey Kitch Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA PubMed articles Google scholar articles

Citation

Maurer D, Yu JX, Sklodowski K, et al

343 Multiomic biomarker signatures identify subsets of patients who may benefit from either nivolumab or sotigalimab in combination with chemotherapy in metastatic pancreatic cancer

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.343

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password